Fact CheckerSign in

NCT06345612Completed

Impact of Eccentric Training in Hypoxia With Creatine on Metabolic Control and VO2max in Patients With Type 1 Diabetes

Impact of Eccentric Training Conducted in the Conditions of Normobaric Hypoxia, Normoxia and Creatine Supplementation on Metabolic Control, Muscle Strength Level, Maximum Oxygen Consumption (VO2max) in Patients With Type 1diabetes Mellitus

Source: ClinicalTrials.gov · Last updated 7 May 2026

Brief summary (registry, in English)

Exercise plays an important role in treatment of diabetes. In recent years exercise training in normobaric hypoxia is used in training programs for athletes and in rehabilitation and also commercially. The aim of the study is to assess the impact of eccentric training conducted in conditions of normobaric hypoxia or normoxia and creatine supplementation on metabolic control: profile and stability of glucose concentration, HbA1c value, hypoglycemia and insulin demand, as well as the level of muscle strength, VO2max and anthropometric parameters

Status (registry)
Completed
Study type
Interventional
Enrollment
28 (actual)
First submitted
23 Feb 2024
Start date
15 Nov 2023
Primary completion date
30 Mar 2025
Lead sponsor
Silesian Centre for Heart Diseases
NCT number
NCT06345612

What you commit to

  • Study type: Interventional
  • Participants enrolled: 28
  • From 15 Nov 2023 to the primary completion date, 30 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • advanced complications of diabetes \[pre-proliferative or proliferative retinopathy, and previous laser therapy, microalbuminuria or overt nephropathy, autonomic neuropathy (including lack of elevated heart rate during physical activity)\],

Other illness

  • history of cardiovascular event or coronary heart disease

Lab values

  • HbA1c \> 8,0%,

Other

  • patients physically active (regular physical activities more than once a week),
  • positive ECG exercise test,

Who the study is looking for

  • type 1 diabetes of at least 10 years duration,
  • low physical activity,
  • BMI:20-31 kg/m2,
  • treated with multiple insulin injections (at least 4 daily) or insulin pump (continuous subcutaneous insulin infusion \[CSII\]),
  • negative ECG exercise test,
  • HbA1c ≤ 8,0%,
  • high knowledge about functional insulin therapy, carbohydrate counting and diabetes management during exercise,
  • experience in use of FreeStyleLibre2 (Flash Glucose Monitoring System, Abbott),
  • Informed consent to participate in research signed by enrolled subjects

Age in the registry: 20 years to 45 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Internal Diseases, Diabetology and Cardiometabolic Disorders, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland
Coordinator of this site? Confirm its status
ZabrzePolandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.